Shield Therapeutics PLC
(LSE:STX)
£
0.02725
0.0005 (1.89%)
Market Cap: 28.39 Mil
Enterprise Value: 37.98 Mil
PE Ratio: 0
PB Ratio: 27.51
GF Score: 0/100 
Half Year 2024 Shield Therapeutics PLC Earnings Presentation Transcript
Sep 04, 2024 / 03:30PM GMT
Release Date Price:
£0.045
(-15.09%)
Operator
Presentation
Sep 04, 2024 / 03:30PM GMT
=====================
Corporate Participants
=====================
* Anders Lundstrom
Shield Therapeutics PLC - Chief Executive Officer
* Santosh Shanbhag
Shield Therapeutics PLC - Chief Financial Officer
=====================
Anders Lundstrom
Shield Therapeutics PLC - Chief Executive Officer
Good afternoon and welcome to Shield Therapeutics PLC investor presentation, (Operator Instructions)
And I'd now like to hand over to the management team from Shield Therapeutics PLC. Anders, good afternoon, sir.
-
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers